Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver

Pregnancy is a complex physiological state, in which the metabolism of endogenous as well as exogenous agents is ostensibly altered. One exogenous agent of concern is the hepatocarcinogen aflatoxin B1(AFB1), a foodborne fungal toxin, that requires phase I metabolic oxidation for conversion to its to...

Full description

Bibliographic Details
Main Authors: Egner, Patricia A., Groopman, John D., Satayavivad, Jutamaad, Sriwattanapong, Kanokwan, Slocum, Stephen L., Chawanthayatham, Supawadee, Fedeles, Bogdan I, Croy, Robert G, Essigmann, John M
Other Authors: Massachusetts Institute of Technology. Center for Environmental Health Sciences
Format: Article
Published: Oxford University Press (OUP) 2018
Online Access:http://hdl.handle.net/1721.1/117600
https://orcid.org/0000-0003-3160-0992
https://orcid.org/0000-0003-0176-1920
https://orcid.org/0000-0001-5252-826X
https://orcid.org/0000-0002-2196-5691
_version_ 1826210795377131520
author Egner, Patricia A.
Groopman, John D.
Satayavivad, Jutamaad
Sriwattanapong, Kanokwan
Slocum, Stephen L.
Chawanthayatham, Supawadee
Fedeles, Bogdan I
Croy, Robert G
Essigmann, John M
author2 Massachusetts Institute of Technology. Center for Environmental Health Sciences
author_facet Massachusetts Institute of Technology. Center for Environmental Health Sciences
Egner, Patricia A.
Groopman, John D.
Satayavivad, Jutamaad
Sriwattanapong, Kanokwan
Slocum, Stephen L.
Chawanthayatham, Supawadee
Fedeles, Bogdan I
Croy, Robert G
Essigmann, John M
author_sort Egner, Patricia A.
collection MIT
description Pregnancy is a complex physiological state, in which the metabolism of endogenous as well as exogenous agents is ostensibly altered. One exogenous agent of concern is the hepatocarcinogen aflatoxin B1(AFB1), a foodborne fungal toxin, that requires phase I metabolic oxidation for conversion to its toxic and carcinogenic form, the AFB1-8,9-exo-epoxide. The epoxide interacts with cellular targets causing toxicity and cell death; these targets include the covalent modification of DNA leading to mutations that can initiate malignant transformation. The main detoxification pathway of the AFB1- epoxide involves phase II metabolic enzymes including the glutathione-S-transferase (GST) family. Pregnancy can modulate both phase I and II metabolism and alter the biological potency of AFB1. The present work investigated the impact of pregnancy on AFB1exposure in mice. A single IP dose of 6 mg/kg AFB1was administered to pregnant C57BL/6 J mice at gestation day 14 and matched non-pregnant controls. Pregnant mice accumulated 2-fold higher AFB1-N7-guanine DNA adducts in the liver when compared with nonpregnant controls 6h post-exposure. Enhanced DNA adduct formation in pregnant animals paralleled elevated hepatic protein expression of mouse CYP1A2 and mouse homologs of human CYP3A4, phase I enzymes capable of bioactivating AFB1. Although phase II enzymes GSTA1/2 showed decreased protein expression, GSTA3, the primary enzymatic protection against the AFB1-epoxide, was unaffected at the protein level. Taken together, our results reveal that pregnancy may constitute a critical window of susceptibility for maternal health, and provide insight into the biochemical factors that could explain the underlying risks.
first_indexed 2024-09-23T14:55:34Z
format Article
id mit-1721.1/117600
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T14:55:34Z
publishDate 2018
publisher Oxford University Press (OUP)
record_format dspace
spelling mit-1721.1/1176002022-10-01T23:24:20Z Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver Egner, Patricia A. Groopman, John D. Satayavivad, Jutamaad Sriwattanapong, Kanokwan Slocum, Stephen L. Chawanthayatham, Supawadee Fedeles, Bogdan I Croy, Robert G Essigmann, John M Massachusetts Institute of Technology. Center for Environmental Health Sciences Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Chemistry Sriwattanapong, Kanokwan Slocum, Stephen L. Chawanthayatham, Supawadee Fedeles, Bogdan I Croy, Robert G Essigmann, John M Pregnancy is a complex physiological state, in which the metabolism of endogenous as well as exogenous agents is ostensibly altered. One exogenous agent of concern is the hepatocarcinogen aflatoxin B1(AFB1), a foodborne fungal toxin, that requires phase I metabolic oxidation for conversion to its toxic and carcinogenic form, the AFB1-8,9-exo-epoxide. The epoxide interacts with cellular targets causing toxicity and cell death; these targets include the covalent modification of DNA leading to mutations that can initiate malignant transformation. The main detoxification pathway of the AFB1- epoxide involves phase II metabolic enzymes including the glutathione-S-transferase (GST) family. Pregnancy can modulate both phase I and II metabolism and alter the biological potency of AFB1. The present work investigated the impact of pregnancy on AFB1exposure in mice. A single IP dose of 6 mg/kg AFB1was administered to pregnant C57BL/6 J mice at gestation day 14 and matched non-pregnant controls. Pregnant mice accumulated 2-fold higher AFB1-N7-guanine DNA adducts in the liver when compared with nonpregnant controls 6h post-exposure. Enhanced DNA adduct formation in pregnant animals paralleled elevated hepatic protein expression of mouse CYP1A2 and mouse homologs of human CYP3A4, phase I enzymes capable of bioactivating AFB1. Although phase II enzymes GSTA1/2 showed decreased protein expression, GSTA3, the primary enzymatic protection against the AFB1-epoxide, was unaffected at the protein level. Taken together, our results reveal that pregnancy may constitute a critical window of susceptibility for maternal health, and provide insight into the biochemical factors that could explain the underlying risks. National Institutes of Health (U.S.) (Grant T32-ES007020) National Institutes of Health (U.S.) (Grant P30-ES002109) National Institutes of Health (U.S.) (Grant R01-ES016313) National Institutes of Health (U.S.) (Grant R01-CA080024) National Institutes of Health (U.S.) (Grant P30-CA006973) 2018-08-28T20:46:49Z 2018-08-28T20:46:49Z 2017-08 2018-08-28T18:20:59Z Article http://purl.org/eprint/type/JournalArticle 1096-6080 1096-0929 http://hdl.handle.net/1721.1/117600 Sriwattanapong, Kanokwan et al. “Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver.” Toxicological Sciences 160, 1 (August 2017): 173–179 © 2017 The Author https://orcid.org/0000-0003-3160-0992 https://orcid.org/0000-0003-0176-1920 https://orcid.org/0000-0001-5252-826X https://orcid.org/0000-0002-2196-5691 http://dx.doi.org/10.1093/TOXSCI/KFX171 Toxicological Sciences Creative Commons Attribution-NonCommercial 4.0 International http://creativecommons.org/licenses/by-nc/4.0/ application/pdf Oxford University Press (OUP) Oxford University Press
spellingShingle Egner, Patricia A.
Groopman, John D.
Satayavivad, Jutamaad
Sriwattanapong, Kanokwan
Slocum, Stephen L.
Chawanthayatham, Supawadee
Fedeles, Bogdan I
Croy, Robert G
Essigmann, John M
Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
title Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
title_full Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
title_fullStr Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
title_full_unstemmed Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
title_short Editor’s Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver
title_sort editor s highlight pregnancy alters aflatoxin b1 metabolism and increases dna damage in mouse liver
url http://hdl.handle.net/1721.1/117600
https://orcid.org/0000-0003-3160-0992
https://orcid.org/0000-0003-0176-1920
https://orcid.org/0000-0001-5252-826X
https://orcid.org/0000-0002-2196-5691
work_keys_str_mv AT egnerpatriciaa editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT groopmanjohnd editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT satayavivadjutamaad editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT sriwattanapongkanokwan editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT slocumstephenl editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT chawanthayathamsupawadee editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT fedelesbogdani editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT croyrobertg editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver
AT essigmannjohnm editorshighlightpregnancyaltersaflatoxinb1metabolismandincreasesdnadamageinmouseliver